Loading…
Bausch Health Companies Inc. is projected to rise to $5.61 by 2027, a +17% move from its current price of $4.78. BHC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.66 | $4.78 | $4.91 | +0.04% |
| Jul 14 | $4.61 | $4.78 | $4.96 | +0.08% |
| Jul 15 | $4.58 | $4.79 | $5.01 | +0.12% |
| Jul 16 | $4.55 | $4.79 | $5.04 | +0.16% |
| Jul 17 | $4.52 | $4.79 | $5.08 | +0.21% |
| Jul 18 | $4.50 | $4.79 | $5.11 | +0.25% |
| Jul 19 | $4.48 | $4.79 | $5.13 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.48 | $4.79 | $5.13 | +0.29% |
| Week 2 | $4.36 | $4.81 | $5.30 | +0.58% |
| Week 3 | $4.28 | $4.82 | $5.43 | +0.87% |
| Week 4 | $4.22 | $4.84 | $5.55 | +1.16% |
| Week 5 | $4.16 | $4.85 | $5.65 | +1.45% |
| Week 6 | $4.11 | $4.86 | $5.75 | +1.74% |
| Week 7 | $4.07 | $4.88 | $5.85 | +2.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health.
The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Headquartered in Laval, Canada.
Bausch Health Companies Inc. (BHC) trades at $4.99 and has a market capitalization of $1.86B, with a rank of 2076. The near-term technical backdrop shows bearish signals, but the long-run forecast outlines meaningful upside potential.
The current price sits near the lower end of a 30-day trading range, which spans $4.34 to $5.73. The 30-day range, along with a Bearish technical sentiment, frames the near-term risk and opportunity as investors weigh the path toward the longer-term forecast.
From a longer-horizon perspective, the forecast maps a clear upward trajectory: the 2030 average is $6.88, the 2040 average is $15.90, and the 2050 average is $32.60, with corresponding ROIs of 37.9, 218.7, and 553.4 respectively. This suggests substantial longer-term upside despite the present short-term softness.
A major floor 11.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.3% away) — a key level to hold.
The nearest ceiling, 13.2% above — a clean break opens room to run.
A major ceiling 23.6% above — clearing it would confirm fresh momentum.
Key BHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.85 | Sell | $4.84 | Sell |
| MA 10 | $4.85 | Sell | $4.87 | Sell |
| MA 20 | $4.90 | Sell | $4.93 | Sell |
| MA 50 | $5.20 | Sell | $5.13 | Sell |
| MA 100 | $5.36 | Sell | $5.41 | Sell |
| MA 200 | $5.96 | Sell | $5.77 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.19 | Neutral |
| Stoch RSI (14) | 52.58 | Neutral |
| CCI (20) | -68.44 | Neutral |
| Williams %R (14) | -81.97 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.42 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 18.03 | Buy |
| TRIX (15) | -0.33 | Sell |
| Awesome (5,34) | -0.20 | Sell |
| Ultimate (7,14,28) | 41.89 | Neutral |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 4.86 | Sell |
| ADX (14) | 14.38 | Neutral |
| ATR (14) | 0.11 | Info |
Bearish sentiment currently dominates the near term.
RSI(14) is 40, and the moving averages show a challenging short-term setup, with SMA50 priced at $5.46 and SMA200 priced at $6.15.
Support sits at $4.95 and resistance at $5.75, while the 30-day price range spans $4.34 to $5.73. These levels highlight a tight window for upside unless momentum shifts.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.67 | $4.78 | $6.32 | 0% | Neutral | |
| $4.49 | $5.61 | $7.41 | +17% | Neutral | |
| $4.62 | $5.94 | $8.12 | +24% | Bullish | |
| $4.44 | $5.83 | $8.19 | +22% | Bullish | |
| $4.64 | $6.20 | $8.93 | +30% | Bullish | |
| $5.11 | $6.96 | $10.22 | +46% | Bullish | |
| $5.92 | $8.19 | $12.25 | +71% | Bullish | |
| $6.50 | $9.13 | $13.90 | +91% | Bullish | |
| $6.14 | $8.75 | $13.52 | +83% | Bullish | |
| $6.25 | $9.03 | $14.16 | +89% | Bullish | |
| $8.56 | $13.18 | $21.92 | +176% | Bullish | |
| $15.12 | $25.90 | $46.99 | +442% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.67 | $4.78 | $5.66 | +0.00% |
| August 2026 | $4.07 | $4.80 | $5.80 | +0.34% |
| September 2026 | $4.18 | $4.96 | $6.07 | +3.47% |
| October 2026 | $4.17 | $4.98 | $6.14 | +0.38% |
| November 2026 | $4.10 | $4.91 | $6.11 | -1.34% |
| December 2026 | $4.19 | $5.05 | $6.32 | +2.76% |
Click any year to see its month-by-month BHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Bausch Health Companies Inc.'s 2026 outlook centres on $4.78, within a $4.67 to $6.32 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BHC could reach as high as $7.41, with a base case around $5.61 and support toward $4.49 — roughly +17% from $4.78. A consolidation phase looks the most probable path here.
Expect BHC to range from $4.62 to $8.12 through 2028. The $5.94 average target implies a +24% move from current prices. That is up +6% on the projected 2027 average. Momentum favours further upside here.
The BHC price prediction for 2029 points to an average of $5.83 (low $4.44, high $8.19) — a potential gain of +22% on today's $4.78. Buyers look set to stay in control over this stretch.
In 2030, BHC is projected to trade between $4.64 and $8.93, averaging $6.20 — a potential gain of +30% from today's $4.78. That is up +6% on the projected 2029 average. Momentum favours further upside here.
Bausch Health Companies Inc.'s 2031 outlook centres on $6.96, within a $5.11 to $10.22 range. That is up +12% on the projected 2030 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BHC could reach as high as $12.25, with a base case around $8.19 and support toward $5.92 — roughly +71% from $4.78. Momentum favours further upside here.
Expect BHC to range from $6.50 to $13.90 through 2033. The $9.13 average target implies a +91% move from current prices. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BHC price prediction for 2034 points to an average of $8.75 (low $6.14, high $13.52) — a potential gain of +83% on today's $4.78. Momentum favours further upside here.
In 2035, BHC is projected to trade between $6.25 and $14.16, averaging $9.03 — a potential gain of +89% from today's $4.78. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Bausch Health Companies Inc.'s 2040 outlook centres on $13.18, within a $8.56 to $21.92 range. That is up +46% on the projected 2035 average. That marks a +176% change versus current levels. Momentum favours further upside here.
By 2050, BHC could reach as high as $46.99, with a base case around $25.90 and support toward $15.12 — roughly +442% from $4.78. Buyers look set to stay in control over this stretch.
Investing $1,000 in BHC today (≈ 209.205021 BHC) could be worth
$5,418.56
+$4,418.56 (+442%) by 2050 · US Dollar
Based on the average projected BHC price of $25.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHCwould be worth at today's price.
$1,000 invested in BHC on Jul 10, 2025 (≈ 151.057404 BHC) would be worth
$722.05
-$277.95 (-27.8%) today · 0.72× · US Dollar
Based on a BHC entry price of $6.62 vs. today's $4.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.9 | $975.51 | -2.4% |
| 1 month ago | $5.15 | $928.16 | -7.2% |
| 3 months ago | $5.6 | $853.57 | -14.6% |
| 6 months ago | $7.49 | $638.18 | -36.2% |
| 1 year ago | $6.62 | $722.05 | -27.8% |
| All time (5.0y) ago | $29.37 | $162.75 | -83.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHC forecast.
Our base-case forecast reaches $9.60 around 2040.
Implied market cap at $9.60: $3.59B
The multi-year forecast paints a bullish path after the near term, with a stepwise rise in the average price through 2030 and beyond. In 2030 the average is $6.88 with a 37.9 RO I, reflecting a continued upward bias from 2026’s near-term neutrality of $4.99. By 2040 the forecasted average reaches $15.90 with an ROI of 218.7, and by 2050 the average climbs to $32.60 with an ROI of 553.4, signaling substantial long-run upside.
The forecast for 2026 shows a min of $4.95, an avg of $4.99, and a max of $6.75, with neutral sentiment. The trajectory remains bullish from 2027 onward, where the avg rises to $5.87 and the max to $7.59, with an ROI of 17.5 and neutral sentiment. The longer-horizon years 2028–2050 carry a bullish signal, culminating in the 2050 max of $55.19 and a 553.4 ROI, underscoring the potential for meaningful appreciation alongside elevated volatility, as indicated by the 40% annualized volatility.
These figures are estimates and not guarantees. They imply potential upside over the coming years but also carry the risk of decline or stagnation if market conditions change.
Tap a question to reveal the answer.
Average price: $6.88; range: $5.30 to $9.56; ROI: 37.9; sentiment: BULLISH.
The yearly forecast shows a path from neutral in 2026 to bullish in later years, with the 2030–2050 averages rising to $6.88, $15.90, and $32.60 and ROIs of 37.9, 218.7, and 553.4 respectively. These are estimates and not guarantees.
Yes—the forecasted maximum by 2050 is $55.19, with an average of $32.60, indicating that $50 could be reached within the projection window.
Bearish sentiment is noted. RSI(14) is 40; SMA50 is $5.46; SMA200 is $6.15. Support is at $4.95 and resistance at $5.75, with a 30-day range of $4.34 to $5.73.
Current price: $4.99; Market cap: $1.86B.
Bausch Health Companies Inc. Community Discussion
0Share your Bausch Health Companies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.